Announcement on Implementation of Dividend Distribution for Q1-Q3 2024
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Implementation of Dividend Distribution for Q1-Q3 2024
Filed with SSE · · 3 pages · Chinese
Release
Xizang Weixinkang Pharmaceutical Co., Ltd. on 6ix
Earlier from Xizang Weixinkang Pharmaceutical
- Announcement on Progress in Repurchasing Shares
- Announcement on Resolution of the 11th Meeting of the 3rd Board of Supervisors
- Announcement on Signing Exclusive License Agreement
- Announcement on Expiration of Shareholding Reduction by Directors and Senior Management Members through Call Auction and the Result of Unreduced Shares
- Announcement on Obtaining Notice of Approval for Drug Clinical Trials by Subsidiary
Later from Xizang Weixinkang Pharmaceutical
- Announcement on Withdrawal of Drug Registration Application by the Subsidiary
- Announcement on Initially Repurchasing Shares through Call Auction
- Announcement on the Renewal of the Wholly-owned Subsidiary's Drug in the Catalogue of Drugs for Basic National Medical Insurance (2024)
- Announcement on Passing the Consistency Evaluation of Generic Drug Quality and Efficacy for Subsidiary Drugs
- Announcement on Implementation Results of Share Repurchase and Share Changes
Follow Xizang Weixinkang Pharmaceutical into a list and get an email when it puts out news.
Follow Xizang Weixinkang Pharmaceutical